bezafibrate has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatta, K; Maruoka, R; Nakamura, K; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Watanabe, A | 1 |
| Hemsley, D; Wray, R | 1 |
2 other study(ies) available for bezafibrate and Vascular Diseases
| Article | Year |
|---|---|
Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Bezafibrate; Carboplatin; Endothelium, Vascular; Female; Genital Neoplasms, Female; Humans; Middle Aged; Nitric Oxide; Paclitaxel; Pilot Projects; PPAR alpha; Triglycerides; Umbilical Veins; Vascular Diseases; Vasodilator Agents | 2015 |
Statin + fibrate combination therapy--fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
Topics: Bezafibrate; Cholesterol; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Treatment Outcome; Triglycerides; Vascular Diseases | 1999 |